Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0W8AI
|
||||
Former ID |
DIB008624
|
||||
Drug Name |
Andromustine
|
||||
Synonyms |
GTx-200; SARM (hormone refractory prostate cancer), GTx; Selective androgen receptor modulator (hormone refractory prostate cancer), GTx; Selective androgen receptor modulator (hormone refractory prostate cancer), Merck & Co
|
||||
Indication | Prostate cancer [ICD9: 185; ICD10:C61] | Investigative | [1572605] | ||
Company |
GTx Inc
|
||||
Target and Pathway | |||||
Target(s) | Androgen receptor | Target Info | Modulator | [1572605] | |
Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
Coregulation of Androgen receptor activity | |||||
Regulation of Androgen receptor activity | |||||
Nongenotropic Androgen signaling | |||||
Regulation of nuclear beta catenin signaling and target gene transcription | |||||
FOXA1 transcription factor network | |||||
Notch-mediated HES/HEY network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.